Supernus Says FDA Recognized Seven-Year ONAPGO Exclusivity
Supernus Pharmaceuticals said the FDA recognized seven years of orphan-drug market exclusivity for ONAPGO, its treatment for motor fluctuations in adults with advanced Parkinson’s disease.
Related stories
Italy Fines Meta €805 Million Over Android Users’ Data Access
Italy’s data protection agency said Meta accessed Android users’ photos and videos without consent or notification.
M impact | REGULATION | Nov 14, 2026, 01:04 PM UTC
Italy Fines Meta $887 Million Over Android Users' Data Access
Italy fined Meta over Android users' data access. The wire headline reports a fine of $887 million.
M impact | REGULATION | Nov 14, 2026, 01:04 PM UTC
Italy Fines Meta €805 Million Over Android User Data
Italy’s data protection agency said it fined Meta Platforms €805 million ($887 million) for allegedly accessing Android users’ photos and videos without consent or informing them.
M impact | REGULATION | Nov 14, 2026, 12:27 PM UTC
Italy fines Meta $887 million over Android data access
Italy fined Meta $887 million over access to Android users’ data, Reuters reported.
M impact | REGULATION | Nov 14, 2026, 12:27 PM UTC
Italy Fines Meta €805 Million Over Alleged Data Use Without Consent
Italy’s data protection agency fined Meta over the alleged use of Android users’ videos and photos without consent.
M impact | REGULATION | Nov 14, 2026, 12:18 PM UTC
Modi’s Office Summons Telecom Secretary Over Fake Court Orders
Two government officials said the summons followed takedowns of more than 100 websites based on fake court orders.
L impact | REGULATION | Nov 14, 2026, 09:10 AM UTC